Atlas Trials

Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A

Clinical trial NCT02610127 · COMPLETED

Trial details

NCT number
NCT02610127
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Study type
OBSERVATIONAL
Acquired Hemophilia A
Start date
2015-12-30
Primary completion
2019-06-07
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.